RIDEQ Financial Statements & Analysis
Complete financial statements for RIDEQ including income statement, balance sheet, and cash flow statement. Analyze RIDEQ's revenue growth, profit margins, earnings trends, debt levels, and cash flow generation.
TTM figures are calculated by rolling up the last four quarterly filings (income and cash flow summed; balance sheet at period end).
Financial Health Score
Financial Health Score
Income Statement
Revenue
-7.7% ↓
Net Income
22.9% ↑
Gross Margin
18.8% ↑
Operating Margin
14.9% ↑
Balance Sheet
Current Ratio
34.1% ↑
Debt to Equity
-100.0% ↑
Asset Turnover
8.2% ↑
Cash Flow
Operating Cash Flow
15.7% ↑
Net Cash Flow
43.4% ↑
Free Cash Flow
16.7% ↑
Cash Flow to Debt
-2706463524.1% ↓
Income Statement Comparison
Revenue & Net Income
Period Comparison
| Metric | TTM Q3 '23 | TTM Q4 '23 | Change | Impact |
|---|---|---|---|---|
| Revenue | 2.53M | 2.34M | 7.7% | |
| Gross Profit | -119.14M | -89.31M | 25.0% | |
| Operating Income | -298.45M | -234.46M | 21.4% | |
| Net Income | -444.72M | -343.06M | 22.9% | |
| EPS | -7.29 | -5.38 | 26.3% | |
| EBITDA | -15.88M | 57.21M | 460.1% | |
| Gross Margin | -4701.58% | -3816.62% | 18.8% | |
| Operating Margin | -11777.66% | -10019.53% | 14.9% | |
| Net Income Margin | -17549.96% | -14660.90% | 16.5% | |
| R&D Expenses | 48.05M | 33.34M | 30.6% |
Income Statement Full Table
Free users can view the last 3 periods. Upgrade to see the full history.
Upgrade| Metric | TTM Q4 '23 | TTM Q3 '23 | TTM Q2 '23 | TTM Q1 '23 | TTM Q4 '22 |
|---|---|---|---|---|---|
| Revenue | 2.34M | 2.53M | 2.53M | — | — |
| Gross Profit | -89.31M | -119.14M | -119.04M | — | — |
| Operating Income | -234.46M | -298.45M | -360.94M | — | — |
| Net Income | -343.06M | -444.72M | -582.64M | — | — |
| EPS | -5.38 | -7.29 | -9.85 | — | — |
| EBITDA | 57.21M | -15.88M | -18.80M | — | — |
| Gross Margin | -3816.62% | -4701.58% | -4697.67% | — | — |
| Operating Margin | -10019.53% | -11777.66% | -14243.69% | — | — |
| Net Income Margin | -14660.90% | -17549.96% | -22992.90% | — | — |
| R&D Expenses | 33.34M | 48.05M | 62.17M | — | — |
Financial Metrics
Want to dive deeper into RIDEQ's financial health? Explore key financial metrics and ratios including profitability, liquidity, efficiency, and valuation metrics.
View Financial Metrics